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Abstract  
ARC syndrome is a rare autosomal recessive disease, characterized by arthrogryposis, renal 
tubular dysfunction and cholestasis. Herein a 2.5 month old infant with dysmorphic features, 
including small anterior fontanel, low set ears, beaked nose and high arched palate is presented 
who was referred because of icterus. He also suffered from some additional anomalies, including 
unilateral choanal atresia, club foot, and bilateral developmental dislocation of hip, while further 
studies showed renal tubular acidosis and hearing impairment in addition to cholestasis. Genetic 
studies showed a homozygous mutation in the VIPAS39 gene. Making the definite diagnosis of 
the syndrome is important, while increased risk of mutation in other siblings highlights the 
importance of prenatal diagnosis. 
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Introduction 
ARC syndrome is a rare disease, characterized by arthrogryposis, renal tubular dysfunction, and 
intrahepatic cholestasis (1). However, there is clinical variability in this syndrome. There are 
some reports showing musculoskeletal manifestations of arthrogryposis multiplex, or association 
of vertical talus, pes calcaneovalgus, hip dislocation, pathologic fractures, and rigid kyphosis in 
affected patients (2). Renal manifestations also varies from isolated renal tubular acidosis to 
severe fanconi syndrome with nephrogenic diabetes insipidus, interstitial nephritis and 
nephrocalcinosis (3,4). Hepatic involvement in ARC syndrome includes intrahepatic biliary 
ducts paucity, lipofuscin deposition, giant cell hepatitis, fibrosis and cirrhosis (4). Meanwhile 
normal hepatic histology could also be seen (5). Unfortunately, the syndrome has no curative 
therapy (6), and most patients die because of recurrent febrile illness and pneumonia before first 
birthday (4,7). ARC syndrome can be caused by homozygous or compound heterozygous mutations in 
VPS33B or VIPAS39 genes (8). Herein, a case with clinical manifestations compatible with ARC 
syndrome is reported, in which the definite diagnosis was made by genetic study. 
 
Case report 
A 2.5-month old male infant, born from consanguineous Iranian parents, was admitted to the 
Children’s Medical Center Hospital, the Pediatrics Center of Excellence in Tehran, Iran because 
of icterus from 3 weeks of age. This infant was the first child of family, born at gestational age of 
35 weeks by cesarean section because of breech presentation. In prenatal evaluation, 
oligohydramnious had been detected. He had a birth weight of 2,700 gram; and was under 
levothyroxin therapy because of hypothyroidism. He has a dysmorphic features, including small 
anterior fontanel, low set ears, beaked nose and high arched palate. Additional anomalies were 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
unilateral choanal atresia, club foot, and bilateral developmental dislocation of hip (DDH). 
Because of his icterus and hepatomegaly, liver investigations were performed, which revealed 
hyperbilirubinemia, mild increased transaminases, greatly increased alkaline phosphatase and 
normal gamma glutamyl transpeptidase (AST=156, ALT=174, AlK=4467, GGT=46, Bil 
total=7.1, Bil direct=3.9, total protein=5.3, albumin=3.2). Hepatic histology showed hepatocyte 
disarray with scattered giant cell transformation intra and extra hepatocytic bile stasis in porta; no 
evidence of necrosis was seen. Portal spaces showed mild inflammation with mild fibrous 
expansion and decreased number of bile ducts. During the course of the admission, the patient 
developed polyuria, metabolic acidosis, glucosuria, phosphaturia, and aminoaciduria, which are 
the characteristics of renal tubular acidosis. Abdominal sonography showed increased 
echogenicity of kidneys. As of suspicious to ARC syndrome, ABR (Auditory Brainstem 
Response) test was performed which was abnormal. Genomic DNA of the patient was screened 
for mutations in VPS33B and VIPAS39 genes using Sanger sequencing and identified a 
homozygous missense c.1130G>C point mutation (SCV000258931) in VIPAS39 which cause 
arginine to proline amino acid change (Arg377Pro). Both parents were found to be heterozygous 
carriers of this mutation (Figure 1). 
 
Discussion 
ARC syndrome is a rare disease that usually manifests by arthrogryposis, renal tubular 
dysfunction and cholestasis. Herein clinical feature of a patient is presented that was similar to 
previous case reports; so, genetic study was done which confirmed the diagnosis. This is the first 
report of the c.1130G>C mutaton in VIPAS39, which encodes VIPAR. Our patient has a severe 
ARC phenotype which suggests that arginine at position 377 is important to VIPAR function (9). 
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Additional feature in our patient was unilateral choanal atresia. There is an increased prevalence of 
autosomal recessive disorders in consanguineous populations. As siblings have one in four chance of 
inheriting the same disorder, the importance of prenatal diagnosis cannot be overemphasized. Therefore 
as mutation is confirmed in this family, prenatal test could be done on chorionic villus sample or 
amniotic fluid. This practice is important, especially in the Middle East region, where there are 
high rate of consanguinity and increased frequency of autosomal recessive disorders (10). 
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Figure 1. A control wild-type sequence with a peak for G and the patient sequence 
with a single peak for C, clearly showing the presence of a mutation (SCV000258931) 
and the fact that it is homozygous. Both parents are heterozygous for the mutation, 
since the electropherogram shows two peaks for G and C in this same position, 
validating the mutation found in the patient. 
